TY  - JOUR
AU  - Novillo Villajos, Apolonia
AU  - Gaibar, María
AU  - Romero Lorca, Alicia
AU  - Malón, Diego
AU  - Antón, Beatriz
AU  - Moreno, Amalia
AU  - Fernández Santander, Ana
PY  - 2023
DO  - 10.3390/cancers15030763
SN  - 2072-6694
UR  - https://hdl.handle.net/20.500.14352/103371
T2  - Cancers
AB  - The addition to chemotherapy of anti-HER2 drugs such as trastuzumab or pertuzumab has improved outcomes in HER2-positive breast cancer patients. However, resistance to these drugs in some patients remains a major concern. This study examines the...
LA  - eng
PB  - MDPI
KW  - HER2-positive breast cancer
KW  - Anti-HER2 treatment
KW  - HER2 gene
KW  - SNPs
KW  - Pathological complete response
KW  - Miller–Payne grading
TI  - HER2 and BARD1 Polymorphisms in Early HER2-Positive Breast Cancer Patients: Relationship with Response to Neoadjuvant Anti-HER2 Treatment
TY  - journal article
VL  - 15
ER  -